SCHEMBL205655

SCHEMBL205655

CCOC(=O)N1CC=Cc2ccccc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.53
LMNA P02545 1/20 0.53
P2RX4 Q99571 5/20 0.44
BCHE P06276 1/20 0.44
GAA P10253 1/20 0.43
MAPK1 P28482 2/20 0.42
ADORA1 P30542 1/20 0.41
P2RX1 P51575 2/20 0.41
P2RX3 P56373 2/20 0.41
PTBP1 P26599 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
P2RX7 Q99572 1/20 0.41
ALDH1A1 P00352 4/20 0.40
NOTUM Q6P988 1/20 0.40
MAPT P10636 3/20 0.40
PKM P14618 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29549990 1.00 SMN1; SMN2 (0.53) SMN1; SMN2LMNAP2RX4BCHEGAA
SCHEMBL6110992 0.90 SMN1; SMN2 (0.44) SMN1; SMN2LMNAP2RX4BCHEGAA
SCHEMBL411007 0.89 SMN1; SMN2 (0.44) SMN1; SMN2LMNAP2RX4BCHEGAA
SCHEMBL29639604 0.89 SMN1; SMN2 (0.44) SMN1; SMN2LMNAP2RX4BCHEGAA
SCHEMBL3719677 0.88 BCHE (0.50) SMN1; SMN2LMNAP2RX4BCHEMAPK1
SCHEMBL6110401 0.86 P2RX4 (0.64) SMN1; SMN2LMNAP2RX4P2RX1P2RX3
SCHEMBL27785934 0.84 P2RX4 (0.58) SMN1; SMN2LMNAP2RX4BCHEGAA
SCHEMBL28802473 0.84 P2RX4 (0.63) SMN1; SMN2P2RX4GAAMAPK1P2RX1
SCHEMBL22264116 0.83 P2RX4 (0.41) SMN1; SMN2LMNAP2RX4BCHEGAA
SCHEMBL8769449 0.82 P2RX4 (0.43) SMN1; SMN2LMNAP2RX4BCHEP2RX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 203 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1670446-A2 METHOD OF INHIBITING REMNANT LIPOPROTEIN PRODUCTION JAPAN TOBACCO INC. (JP) 2006-06-21 EP claimed
WO-2006033004-A1 QUINOLINE COMPOUNDS AS CETP INHIBITORS PFIZER PRODUCTS INC. (US) 2006-03-30 WO claimed
WO-2005030185-A2 METHOD OF INHIBITING REMNANT LIPOPROTEIN PRODUCTION JAPAN TOBACCO INC. (JP) 2005-04-07 WO claimed
EP-1305007-A2 PHARMACEUTICAL COMPOSITIONS OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS Pfizer Products Inc. (US) 2003-05-02 EP claimed
WO-2002022618-A1 METHOD FOR PREPARING CAMPTOTHECIN AND ITS DERIVATIVES AVENTIS PHARMA S.A. (FR) 2002-03-21 WO claimed
WO-2002011710-A2 PHARMACEUTICAL COMPOSITIONS OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS PFIZER PRODUCTS INC. (US) 2002-02-14 WO claimed
CN-119954828-A Parallel ring compound and preparation and application thereof 石药集团中奇制药技术(石家庄)有限公司 2025-05-09 CN disclosed
CN-116322699-B Parallel ring compound and preparation and application thereof 石药集团中奇制药技术(石家庄)有限公司 2025-02-11 CN disclosed
CN-116322699-A Parallel ring compound and preparation and application thereof 石药集团中奇制药技术(石家庄)有限公司 2023-06-23 CN disclosed
CN-114591212-A Human plasma kallikrein inhibitors 拜奥克里斯特制药公司 2022-06-07 CN disclosed
WO-2022063303-A1 A CLASS OF FUSED RING COMPOUNDS, AND PREPARATION AND USE THEREOF 石药集团中奇制药技术(石家庄)有限公司 2022-03-31 WO disclosed
WO-2021161263-A1 GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF ABBVIE INC. (US) 2021-08-19 WO disclosed
EP-3560923-B1 ANTI PARASITIC DIHYDROAZOLE COMPOUNDS AND COMPOSITIONS COMPRISING SAME BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC (US) 2021-05-05 EP disclosed
EP-0053537-A1 Vinyl-3 cephalosporin derivatives and their preparation RHONE-POULENC SANTE (FR) 1982-06-09 EP disclosed
EP-0053542-A1 Cephalosporin derivatives, their preparation and pharmaceutical compositions containing them RHONE-POULENC SANTE (FR) 1982-06-09 EP disclosed
EP-0053540-A1 Cephalosporin derivatives and their preparation RHONE-POULENC SANTE (FR) 1982-06-09 EP disclosed
EP-0053539-A1 Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them RHONE-POULENC SANTE (FR) 1982-06-09 EP disclosed
EP-0053072-A1 Oxacephalosporins and their preparation RHONE-POULENC SANTE (FR) 1982-06-02 EP disclosed
EP-0053073-A1 Oxacephalosporins and their preparation RHONE-POULENC SANTE (FR) 1982-06-02 EP disclosed
EP-0053074-A1 Cephalosporin derivatives and their preparation RHONE-POULENC SANTE (FR) 1982-06-02 EP disclosed